Cannabis stocks fall after FDA hearing on CBD finds conflicting views of substance

By Ciara Linnane

“The U.S. Food and Drug Administrationconducted its first-ever hearing on cannabis and its nonintoxicating ingredient CBD all day Friday with more than 100 speakers offering views, including researchers, health professionals, advocates, manufacturers and opponents”

Read more

Leave a comment